Hun-Sik Wang
Chief Executive Officer presso GL PHARM TECH CORP.
Patrimonio netto: 1 M $ in data 31/03/2024
Profilo
Hun-Sik Wang is currently the Chief Executive Officer and Director at GL Pharm Tech Corp.
Prior to this, he was the Chief Executive Officer at GL PharmTech, Inc. and Co-Chief Executive Officer at Crown Pharm Co., Ltd.
He holds a doctorate degree from Chungnam National University and a graduate degree from Chung-Ang University.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
GL PHARM TECH CORP.
1.30% | 06/03/2024 | 993 323 ( 1.30% ) | 1 M $ | 31/03/2024 |
Posizioni attive di Hun-Sik Wang
| Società | Posizione | Inizio |
|---|---|---|
| GL PHARM TECH CORP. | Chief Executive Officer | 01/08/2002 |
Precedenti posizioni note di Hun-Sik Wang
| Società | Posizione | Fine |
|---|---|---|
Crown Pharm Co., Ltd.
 Crown Pharm Co., Ltd. Pharmaceuticals: OtherHealth Technology Crown Pharm Co., Ltd. manufactures medicine and other related products. Its products include Sexcon, Haisoming A, Ganeca, Denti F, Traming, entas, Smer, Alpina, Muspan, Mg-pherol, Picolax, Glutase, and Cragel. The company was founded on February 9, 1985 and is headquartered in Anyang, South Korea. | Chief Executive Officer | - |
GL PharmTech, Inc. /Old/
 GL PharmTech, Inc. /Old/ Pharmaceuticals: MajorHealth Technology GL PharmTech, Inc. develops and manufactures new drugs and pharmaceuticals. Its products include incrementally modified and generic drugs and Artemisia leaf extract tablets. The company was founded in August 2002 and is headquartered in Seongnam, South Korea. | Chief Executive Officer | - |
Formazione di Hun-Sik Wang
| Chungnam National University | Doctorate Degree |
| Chung-Ang University | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 3 |
|---|---|
GL PharmTech, Inc. /Old/
GL PharmTech, Inc. /Old/ Pharmaceuticals: MajorHealth Technology GL PharmTech, Inc. develops and manufactures new drugs and pharmaceuticals. Its products include incrementally modified and generic drugs and Artemisia leaf extract tablets. The company was founded in August 2002 and is headquartered in Seongnam, South Korea. | Health Technology |
| GL Pharm Tech Corp. | |
Crown Pharm Co., Ltd.
Crown Pharm Co., Ltd. Pharmaceuticals: OtherHealth Technology Crown Pharm Co., Ltd. manufactures medicine and other related products. Its products include Sexcon, Haisoming A, Ganeca, Denti F, Traming, entas, Smer, Alpina, Muspan, Mg-pherol, Picolax, Glutase, and Cragel. The company was founded on February 9, 1985 and is headquartered in Anyang, South Korea. | Health Technology |
- Borsa valori
- Insiders
- Hun-Sik Wang
